Each GLP-1 medication has a slightly different profile in terms of duration of action, gastrointestinal effects, and individual response
To date, no clear clinical evidence has suggested a tumorigenic effect of GLP-1 RAs [24-26], yet the steadily increasing use of these agents worldwide emphasizes the importance of thoroughly evaluating their potential association with cancer risk
Reclaim your health with the effortless, clinically proven power of Lenreey SMGT-GLP-1 Nano Microneedle Patch
KFF Health Tracking Poll May 2024: The Publics Use and Views of GLP-1 Drugs. KFF
[DOI] [PubMed] [Google Scholar] 133.Vallianou N.G., Dalamaga M., Pavlou A., Rebelos E., Karamanolis N.N., Papachristoforou E., Mavrothalassitis E., Eleftheriadou I., Tentolouris N., Kounatidis D